Ecolab Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

ECL Stock Up in Pre-Market Post In-Line Q1 Earnings, Gross Margin Down

AI-generated analysis

Ecolab (ECL) reported first-quarter 2026 adjusted EPS of $1.70, matching analyst estimates and driving shares up nearly 1% in pre-market trading.

GAAP EPS reached $1.52, representing a 7.8% year-over-year increase, while revenues totaled $4.07 billion, beating consensus by 1.1%.

Organic sales grew 3.5% to $3.96 billion, with the Global Water segment contributing $2.04 billion in fixed currency sales led by high-tech growth.

The Institutional & Specialty segments delivered 3.6% combined organic growth, driven by hospitality gains and value pricing in specialty units.

Global Pest Elimination saw strong organic growth of 7.3%, supported by new business wins in restaurants and healthcare.

Life Sciences arm grew 10.7% organically, primarily due to a doubling of sales in the bioprocessing unit.

Gross profit increased 8.3% to $1.77 billion, but the gross margin contracted 69 basis points to 43.6% amid softer demand in Heavy Water and Paper.

Operating expenses rose 4.9% year-over-year to $1.10 billion, while adjusted operating profit expanded 14.3% to $668.4 million with an improved margin of 16.4%.

The company reduced its cash and cash equivalents balance to $519.8 million, slightly below the previous quarter’s $646.2 million, while total debt increased to $8.49 billion.

Ecolab maintains a consistent dividend history with five-year annualized dividend growth of 8.75%, reinforcing its status as an attractive income play.

Management revised full-year 2026 guidance upward, expecting organic sales growth of 6%-7% including the Ovivo Electronics acquisition.

Second-quarter 2026 adjusted EPS is now forecast between $2.02 and $2.12, compared to a Zacks Consensus Estimate of $2.13.

Full-year 2026 adjusted EPS guidance stands at $8.43-$8.63, reflecting a 12%-15% increase from the prior year’s reported number.

Analysts attribute strong performance to value pricing, volume growth, and productivity improvements under the company's technology-led model.

Despite robust segment performance, soft market demand in Heavy Water and Paper remains a headwind impacting overall gross margin expansion.

The stock currently carries a Zacks Rank #3 (Hold), with management highlighting the strength of its core business units as a positive for investors.

Other medical sector stocks like DexCom are expected to report soon, offering alternative growth opportunities in the broader healthcare space.

Bullish Signals
  • Ecolab reported first-quarter adjusted EPS of $1.70, which was in line with analyst estimates while GAAP EPS reached $1.52, representing a strong 7.8% year-over-year increase.
  • Revenues grossed $4.07 billion, topping the Zacks Consensus Estimate by 1.1% and demonstrating resilient top-line growth despite market headwinds.
  • Ecolab's Digital sales surged 24% to $99 million, driven by robust double-digit growth across both software and enabling hardware subscriptions.
  • The Global Water segment achieved fixed currency sales of $2.04 billion with 7.1% year-over-year growth, bolstered by organic sales increases and a strategic 5% benefit from the Ovivo Electronics acquisition.
  • Global High-Tech within the water segment delivered more than 20% organic growth, reflecting exceptionally robust expansion in microelectronics and data centers.
  • The Global Institutional & Specialty arm saw fixed currency and organic sales rise 3.6% to $1.51 billion, driven by strong hospitality growth and high-single digit increases in specialty unit sales.
  • Global Pest Elimination reported fixed currency sales of $310.1 million with a 7.9% year-over-year improvement, supported by solid organic gains across restaurants, retail, and healthcare sectors.
  • The Global Life Sciences arm achieved 10.7% year-over-year growth on both fixed currency and organic sales, driven notably by bioprocessing which more than doubled its sales during the quarter.
  • Adjusted operating profit increased 14.3% to $668.4 million, resulting in an expanded adjusted operating margin of 16.4%, demonstrating effective cost management and operational leverage.
  • Management revised 2026 guidance upward, now expecting reported sales to increase 9%-11% compared with the prior outlook of 7%-9%, indicating improved confidence in demand.
  • Ecolab is raising its full-year 2026 adjusted EPS expectation to $8.43-$8.63, signaling an anticipated uptick of 12%-15% from the comparable 2025 period.
  • The company maintains a consistent dividend-paying history with a five-year annualized dividend growth of 8.75%, providing attractive income stability for investors.
Risk Factors
  • Gross margin contracted 69 basis points to 43.6% despite revenues growing 10%, raising concerns about pricing power or cost inflation.
  • The company exited the first quarter with cash and cash equivalents of $519.8 million, a decline from $646.2 million at the end of the fourth quarter of 2025.
  • Total debt increased to $8.49 billion from $8.24 billion in the prior quarter, worsening the company's balance sheet leverage.
  • Heavy Water and Paper segments experienced softer sales headwinds that required stabilization from other segments.
  • The company faces temporary capacity constraints within its Life Sciences' industrial water purification business.
  • Second-quarter adjusted EPS guidance ($2.02 to $2.12) falls below the Zacks Consensus Estimate of $2.13.
Full Analysis
Ecolab Inc. (ECL) reported first-quarter 2026 financial results that saw adjusted earnings per share (EPS) of $1.70, aligning with analyst consensus estimates and representing a 13.3% year-over-year increase. On the revenue front, the company grossed $4.07 billion, surpassing expectations by 1.1% and marking a 10% rise year over year, while organic sales grew 3.5% to $3.96 billion. Ecolab Digital saw significant momentum with a 24% surge in sales to $99 million, supported by growth in both software and hardware subscriptions. Performance was robust across most business segments, particularly Global Water which posted 7.1% fixed currency growth driven by its Ovivo Electronics acquisition and strong high-tech segment performance exceeding 20% organic growth. The Global Institutional & Specialty arm also improved with 3.6% growth, led by hospitality customers and specialty unit value pricing. However, the company faced headwinds in Heavy Water and Paper segments due to softer sales, contributing to a contraction in gross margin by 69 basis points to 43.6% despite an 8.3% increase in gross profit dollars. Management provided revised guidance for the second quarter and full year 2026, reflecting the inclusion of the Ovivo Electronics acquisition. For Q2 2026, adjusted EPS is expected between $2.02 and $2.12, slightly below the $2.13 consensus estimate. For full-year 2026, Ecolab raised its reported sales outlook to a 9%-11% increase and organic sales to a 6%-7% rise, while maintaining an adjusted EPS guidance range of $8.43 to $8.63. The company's cash position stands at $519.8 million with total debt at $8.49 billion as of the end of the quarter. The stock price gained nearly 0.9% in pre-market trading on the report, though analysts noted that the contraction in gross margin and ongoing soft market demand in certain segments were concerns. Despite these mixed signals, the overall performance demonstrated strength in its technology- and service-led model through value pricing and productivity improvements. Ecolab maintains a Zacks Rank #3 (Hold) classification based on current analyst estimates and expectations for future earnings growth.